Author:
Stamouli Marilena,Seitopoulou Christina,Kalliora Georgia,Renesi Nikoletta,Mourtzikou Antonia
Abstract
The novel coronavirus SARS-CoV-2 has been the contributing factor to the COVID-19 disease pandemic, since early 2020. It first appeared in December 2019 and since then rapidly spread worldwide. The severe symptoms of COVID-19 disease, especially in the population groups with higher risk of infection or disease complications, along with the increased mortality rates determined the need for adequate protection and prevention measures to be taken. From the beginning of the pandemic, efforts have been made to develop and produce vaccines that could stop the spread of the disease. The vaccination in most countries was performed in phases, with priority to population groups with a higher risk of infection or disease complications, such as the elderly and patients with chronic diseases, and to population groups with a high risk of professional exposure. This study presented data from the vaccination program, implemented at a primary healthcare center in Greece, that served as a vaccination center during the pandemic. Relying on the results, both the attendance rate and the vaccination rate were very high, which proves that the necessity of the vaccine is well established and that vaccination hesitancy is mitigated among the population served at the Nikea Health Center.
Publisher
European Open Science Publishing
Reference12 articles.
1. She J, Hou D, Chen C, Bi J, Song Y. Challenges of vaccination and herd immunity in COVID-19 and management strategies. Clin Respir J. 2022;16(11):708–16. doi: 10.1111/crj.13543.
2. Arnold JN, Gundlach N, Böckelmann I, Sammito S. Vaccination coverage rates of military personnel worldwide: a systematic review of the literature. IntArchOccup Environ Health. 2021;94(1):1–8. doi: 10.1007/s00420-020-01559-w.
3. Who.int. Weekly epidemiological update on COVID-19—May 2023. [Internet]. World Health Organization; 2023 [updated 2023 May 25; cited 2023 November 6]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-oncovid-19. 25-may-2023.
4. EMA(European Medicines Agency) regular press briefing on public health emergencies. 6-6-2023. Available from: https://www.ema.europa.eu/en.
5. Liu H, Zhang J, Cai J, Deng X, Peng C, Chen X, et al. Herd immunity induced by COVID-19 vaccination programs to suppress epidemics caused by SARS-CoV-2 wild type and variants in China. 2021. doi: 10.1101/2021.07.23.21261013. medRxiv: 2021.07.23.21261013.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献